- Oncolytics Biotech completed a corporate domicile change to United States, shifting incorporation from Alberta to Nevada.
- San Diego office becomes new headquarters, while Calgary office is retained.
- Domestication took effect March 31, 2026 following filings with Nevada Secretary of State.
- Nasdaq listing remains under ONCY.
- Company cited operational efficiency, streamlined regulatory structure, improved access to U.S. capital markets.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncolytics Biotech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604010900PRIMZONEFULLFEED9682299) on April 01, 2026, and is solely responsible for the information contained therein.
Comments